Abstract
The report covers a forecast and an analysis of the viral vectors and plasmid DNA manufacturing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the viral vectors and plasmid DNA manufacturing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the viral vectors and plasmid DNA manufacturing market on a global level.
In order to give the users of this report a comprehensive view of the viral vectors and plasmid DNA manufacturing market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The study provides a decisive view of the viral vectors and plasmid DNA manufacturing market by segmenting the market based on product type, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By product type, the market is segmented into viral vectors and plasmid. The viral vectors are further segmented into a retrovirus, lentiviruses, adenoviruses, adeno-associated viruses, and others. The plasmid segment includes DNA conjugative plasmids and non-conjugative plasmids. By application, the market for viral vectors and plasmid DNA manufacturing is segmented into gene and cancer therapies, viral infections, immunotherapy, formulation development, and others. By end-user, the market is segmented into biotechnology companies, research institutes, hospitals, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further division into major countries including the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes the demand for viral vectors and plasmid DNA manufacturing market based on individual product type, application, and end-user in all the regions and countries.
The report also includes detailed profiles of various end players, such as Vigene Biosciences Inc., Lonza, FinVector Vision Therapies, Kaneka Corporation (Eurogentec), VGXI, Inc., VIROVEK, SIRION Biotech GmbH, Cobra Biologics, Novasep, FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc., Genzyme Corporation, ALDEVRON, Brammer Bio, Oxford Gene Technology, and General Electric Company (GE Healthcare), among others.
This report segments the global viral vectors and plasmid DNA manufacturing market into:
Global Viral Vectors and Plasmid DNA Manufacturing Market: Product Type Analysis
Viral Vectors
Retrovirus
Lentiviruses
Adenoviruses
Adeno-Associated Viruses
Others
Plasmids
DNA Conjugative Plasmids
Non-Conjugative Plasmids
Global Viral Vectors and Plasmid DNA Manufacturing Market: Application Analysis
Gene and Cancer Therapies
Viral Infections
Immunotherapy
Formulation Development
Others
Global Viral Vectors and Plasmid DNA Manufacturing Market: End-User Analysis
Biopharmaceutical Companies
Research Institutes
Others?
Global Viral Vectors and Plasmid DNA Manufacturing Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa